Greenland Mines Ltd

GRML

Market cap $54.7M

CHARLOTTE, N.C., April 27, 2026 /PRNewswire/ -- Greenland Mines Ltd (Nasdaq: GRML) ("Greenland Mines" or the "Company") announces the appointment of SLR Consulting ("SLR") as geological consultant and Qualified Person for the Company's Skaergaard Project in East Greenland.

Establishes end-to-end processing and pilot testing program to unlock multi-metal value at Skaergaard CHARLOTTE, N.C., April 23, 2026 /PRNewswire/ -- Greenland Mines Ltd ("Greenland Mines" or the "Company") (Nasdaq: GRML) announces that it has entered into a framework agreement with GTK Mintec, the mineral processing and circular‑economy pilot plant of the Geological Survey of Finland (GTK).

CHARLOTTE, N.C., April 16, 2026 /PRNewswire/ -- Greenland Mines Ltd ("Greenland Mines" or the "Company") (Nasdaq: GRML) has entered into a non-binding Letter of Intent with an Icelandic industrial site owner, providing a concrete framework for technical, commercial, and permitting discussions.

Enhances stakeholder engagement and supports long-term project development in Greenland CHARLOTTE, N.C., April 2, 2026 /PRNewswire/ -- Greenland Mines Ltd (Nasdaq: GRML) ("Greenland Mines" or the "Company"), through its 80%-owned Greenlandic subsidiary Major Precious Greenland A/S ("MPG"), announces that MPG has become a member of Greenland Business Association (Sulisitsisut), the leading organization representing businesses across Greenland.

Ice-class vessel deployment strengthens Arctic logistics infrastructure and enables efficient execution of the 2026 Skaergaard field program CHARLOTTE, N.C., March 25, 2026 /PRNewswire/ -- Greenland Mines Ltd.

Extension reflects Company's continued compliance with all other applicable Nasdaq listing requirements CHARLOTTE, N.C., March 23, 2026 /PRNewswire/ -- Greenland Mines Ltd (Nasdaq: GRML) ("Greenland Mines" or the "Company") today announced that it has received formal notification from The Nasdaq Stock Market LLC ("Nasdaq") granting the Company an additional 180-day period, through September 14, 2026, to regain compliance with Nasdaq's minimum bid price requirement.

Engagement supports exploitation license pathway while advancing responsible, large-scale development of the Skaergaard Project CHARLOTTE, N.C., March 19, 2026 /PRNewswire/ -- Greenland Mines Ltd ("Greenland Mines" or the "Company") (Nasdaq: GRML) is pleased to announce that it has entered into a consultancy agreement with WSP Danmark A/S ("WSP Denmark"), part of the global WSP group, to design and implement a full Environmental Impact Assessment ("EIA") baseline program at the Company's Skaergaard Gold-Palladium-Platinum and Critical Metal Project in eastern Greenland.

Company to hold investor webcast on March 12, 2026 at 4:15PM ET to discuss its expanded focus on critical minerals development in Greenland CHARLOTTE, N.C., March 12, 2026 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO) ("Klotho" or the "Company") today announces that it changed its corporate name to Greenland Mines Ltd and its stock ticker to "GRML" effective at market open today, Thursday, March 12, 2026.

Transaction delivers shareholders direct ownership in one of the largest undeveloped palladium-gold deposits on Earth, establishing a new western champion in critical mineral supply security; Company to rebrand as Greenland Mines CHARLOTTE, N.C. and NUUK, Greenland, March 4, 2026 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO) ("Klotho" or the "Company") today announces the acquisition of Greenland Mines Corp. ("Greenland Mines" or "GMC"), a privately held Delaware corporation that controls an 80% interest in, and an option to acquire the remaining 20% of, the Skaergaard Project in Southeast Greenland — one of the largest and most significant undeveloped palladium, gold, and platinum deposits in the world.

The Company enlists industry veteran Dr. Bret Barnes to oversee the development of new diagnostic offerings NEW YORK, Feb. 24, 2026 /PRNewswire/ -- Klotho Neurosciences, Inc. ("Klotho" or the Company) announces the development of two genomics-based diagnostic tests that will be utilized in Klotho's clinical trials and to be provided as a service in the field of longevity and the understanding of the relationships between biological age and chronologic age.   One genomics test being developed is a quantitative DNA methylation assay that determines the extent of DNA methylation of the anti-aging gene called alpha-Klotho using cell-free DNA isolated through a blood draw as a validated marker of biologic aging.